TOYOHARA, JUNAL-QAHTANI, MOHAMMEDHUANG, YA-YAOCAZZOLA, EMILIANOTODDE, SERGIOFURUMOTO, SHOZOMIKOLAJCZAK, RENATADECRISTOFORO, CLEMENSGILLINGS, NICYANG, MINREILLY, RAYMONDDUATTI, ADRIANODENKOVA, ANTONIASCHIRRMACHER, RALFCARLUCCI, GIUSEPPESEIMBILLE, YANNLIU, ZHAOFEIELLIS, BEVERLEYT. CORNELISSEN, BARTKOPKA, KLAUSBERNARDES, EMERSON2022-12-062022-12-062022TOYOHARA, JUN; AL-QAHTANI, MOHAMMED; HUANG, YA-YAO; CAZZOLA, EMILIANO; TODDE, SERGIO; FURUMOTO, SHOZO; MIKOLAJCZAK, RENATA; DECRISTOFORO, CLEMENS; GILLINGS, NIC; YANG, MIN; REILLY, RAYMOND; DUATTI, ADRIANO; DENKOVA, ANTONIA; SCHIRRMACHER, RALF; CARLUCCI, GIUSEPPE; SEIMBILLE, YANN; LIU, ZHAOFEI; ELLIS, BEVERLEY; T. CORNELISSEN, BART; KOPKA, KLAUS; BERNARDES, EMERSON. Highlight selection of radiochemistry and radiopharmacy developments by editorial board. <b>EJNMMI Radiopharmacy and Chemistry</b>, v. 7, n. 1, p. 1-18, 2022. DOI: <a href="https://dx.doi.org/10.1186/s41181-022-00177-w">10.1186/s41181-022-00177-w</a>. Disponível em: http://repositorio.ipen.br/handle/123456789/33411.2365-421Xhttp://repositorio.ipen.br/handle/123456789/33411Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.1-18openAccessradiochemistryradiopharmaceuticalsnuclear medicineinformationscientific personnelArtigo de periódico1710.1186/s41181-022-00177-w0000-0002-0029-7313https://orcid.org/0000-0002-0029-7313Sem Percentil84.25